Fundz

DiaMedica Therapeutics raised $30 million in a private placement to accelerate its preeclampsia and fetal growth restriction pipeline, led by current investors.

PUBLIC · DMACJul 21, 2025

Amount Raised

$30 Million

Round Type

Post-IPO Equity

MinneapolisBiotechnologyHealth CareTherapeuticsBiopharma

Description

DiaMedica Therapeutics Inc. announced definitive agreements for a $30.1 million private placement of common shares. The funds will support the company’s operations and upcoming milestones, including an IND application and a Phase 2b study for DM199. This financing enables rapid development efforts for conditions with no approved treatments

Quick answer

DiaMedica Therapeutics raised $30 Million in a Post-IPO Equity round, dated July 21, 2025. DiaMedica Therapeutics is based in Minneapolis, Minnesota, United States.

How much did DiaMedica Therapeutics raise?
DiaMedica Therapeutics raised $30 Million in a Post-IPO Equity round on July 21, 2025.
What does DiaMedica Therapeutics do?
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), is a clinical-stage biopharmaceutical company that is focused on developing novel treatments where there is significant unmet clinical need or where no current therapies are..
Where is DiaMedica Therapeutics based and how big is it?
DiaMedica Therapeutics is based in Minneapolis, Minnesota, United States. Fundz records about 38 employees.
Who are the decision-makers at DiaMedica Therapeutics?
Fundz holds 1 contact at DiaMedica Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as DiaMedica Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Os Therapies raised $3.8M on September 2, 2025.
  • TNF Pharmaceuticals raised $7M on September 2, 2025.
  • Lysoway Therapeutics raised $2.9M (Seed) on August 6, 2025.
  • Retension Pharmaceuticals raised $15M (Series B) on August 6, 2025.
  • GenSight Biologics raised $580K (Seed) on July 17, 2025.
  • Os Therapies raised $4.2M on June 23, 2025.

Who to call at DiaMedica Therapeutics, and when

A new round usually means DiaMedica Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DiaMedica Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DiaMedica Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DiaMedica Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DiaMedica Therapeutics

Location

301 CARLSON PARKWAY

Minneapolis, Minnesota, United States

About

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), is a clinical-stage biopharmaceutical company that is focused on developing novel treatments where there is significant unmet clinical need or where no current therapies are available, with the focus on acute ischemic stroke and preeclampsia.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DiaMedica Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts9 people are listed at DiaMedica Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for DiaMedica Therapeutics's next move

See what Strategic adds

DiaMedica Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.